Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants New York, NY…
Updates from the 2022 American Society of Hematology Annual Meeting The Lymphoma Research Foundation (LRF)…
ASH 2022: Primary Central Nervous System Lymphoma Survival Improved with Consolidation Therapy Consolidation with either…
ASH 2022: Addition of Lenalidomide to Rituximab Therapy is Associated with Improved Survival in Relapsed/Refractory…
ASH 2022: Updated Index Improves Prognostication for Survival in Advanced-Stage Hodgkin Lymphoma Models that have…
ASH 2022: Durable Responses Observed with Mosunetuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma In research presented…
ASH 2022: Quality of Life Improves Quickly in Survivors of Aggressive Lymphomas Lymphomas are a…
Stay informed with news, alerts and other resources.
